Printer Friendly
The Free Library
14,557,981 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

J.M. Dutton & Associates Announces Investment Opinion: Aastrom Biosciences Rating Raised to Strong Speculative Buy.


Business Editors

NOTE TO EDITORS: The following is an investment opinion issued by

J.M. Dutton & Associates

EL DORADO El Dorado, legendary country of South America
El Dorado (ĕl`dərä`dō, –rā`–) [Span.,=the gilded man], legendary country of the Golden Man sought by adventurers in South America.
 HILLS, Calif.--(BUSINESS WIRE)--April 10, 2003

J.M. Dutton & Associates continues coverage of Aastrom Biosciences (Nasdaq:ASTM ASTM
abbr.
American Society for Testing and Materials
) with its update report raising its rating to Strong Speculative Buy. The 6-page report by J.M. Dutton senior analyst Sherry Grisewood, CFA (Computer Fraud and Abuse Act of 1986) Signed into law in 1986, the CFA was a significant step forward in criminalizing unauthorized access to computer systems and networks. The Act applies to "federal interest computers" that include any system used by the U.S. , is available at www.jmdutton.com, as well as from Bloomberg, First Call, Zacks, First Call, Multex, and other leading financial portals Financial Portal

A website that provides a variety of financial data and information, acting as an information hub for clients who are individual investors requiring timely financial news and data to make their investment decisions.
.

Aastrom is experiencing increasing commercial sales of its cell production products. Installations of the Company's AastromReplicell(TM) System for cell replication; the DC-I dendritic cell dendritic cell
n.
1. A cell that has branching processes.

2. Any of the cells in the neural crest of the embryonic ectoderm having extensive processes and developing early as producers of melanin.
 product for fusion and transfection trans·fec·tion
n.
Infection of a bacterium or cell with DNA or RNA isolated from a bacteriophage or from an animal or a plant virus, resulting in replication of the complete virus.
 cell-based therapeutics; the DCV-I antigen-loaded dendritic cell complex; and DCV-II, peptide- loaded dendritic cells at academic research and commercial cancer vaccine The term cancer vaccine is often used to describe a process whereby a person's immune system is coaxed into recognizing and destroying malignant cells without harming normal cells.  development organizations in Europe increased by 20% in the December quarter with its 15 installations of the AastromReplicell(TM) System in Europe and the U.S. On April 1, Aastrom announced the results of a study in which the Company's Tissue Repair Cells (TRCs) were used to safely generate bone in a girl with the genetic bone disease hypophosphatasia. Our rationale for the rating upgrade is underpinned by the Company's progress, the recent infusion of capital and, in our view, the misguided selling pressure in the Company's shares as a result of investor confusion and concern over the Company's listing status.

About Dutton & Associates

Dutton & Associates is one of the largest independent investment research firms in the U.S. Its 19 senior analysts, primarily CFAs, have expertise in many industries, including healthcare, technology, finance, banking, mining, gaming, and energy. Dutton & Associates provides economically bias-free, continuing analyst coverage of enrolled companies, and its research, estimates, and recommendations are carried in all the major databases serving institutions and online investors.

The cost of enrollment in the Dutton & Associates one-year continuing research program is presently US$25,000, prepaid pre·pay  
tr.v. pre·paid, pre·pay·ing, pre·pays
To pay or pay for beforehand.



pre·payment n.
 before commencement of its research activities. Dutton & Associates received $22,000 from the Company for coverage for the year. Dutton & Associates does not accept payment of any of its fees in company stock. Its principals and analysts are prohibited from owning or trading in securities of covered companies. Please review full disclosures, analyst background, and company rating history at www.jmdutton.com before investing.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 10, 2003
Words:383
Previous Article:Western Europe Demand for Natural & Wood Plastic Composites to Grow at 19% Per Year Through 2010 Based on New Principia Report.
Next Article:Riveting Film on Child Abuse Takes the Stage at Sonoma Valley Film Festival.



Related Articles
Dutton & Associates Announces Investment Opinion: Aastrom Biosciences Speculative Buy Rating Issued In Initial Report By Dutton & Associates.
J.M. Dutton & Associates Announces Investment Opinion: Riviera Tool Speculative Buy Rating in Update Report by Dutton & Associates.
J.M. Dutton & Associates Announces Investment Opinion: CytoGenix Speculative Buy Rating Maintained in Update Report by Dutton & Associates.
Dutton & Associates Announces Investment Opinion: SCB Computer Strong Speculative Buy Rating Issued by Dutton & Associates.
J.M. Dutton & Associates Announces Investment Opinion: Aastrom Biosciences Rating Maintained at Strong Speculative Buy by Dutton & Associates.
J.M. Dutton & Associates Announces Investment Opinion: SCB Computer Technology: Upgrade To Strong Buy Rating By Dutton & Associates.
JM Dutton & Associates Announces Investment Opinion on Aastrom Biosciences: Aastrom Biosciences Strong Speculative Buy Rating Maintained in Update...
J.M. Dutton & Associates Announces Investment Opinion: Pharmos Corporation Speculative Buy Rating Maintained In Update Report By Dutton & Associates.
J.M. Dutton & Associates Announces Investment Opinion: Cap Rock Energy Strong Speculative Buy Rating Maintained by Dutton & Associates.
J.M. Dutton & Associates Announces Investment Opinion: Neoprobe Strong Speculative Buy Rating Maintained by Dutton & Associates.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles